343 related articles for article (PubMed ID: 27931691)
1. Risk assessment of hepatotoxicity among tuberculosis and human immunodeficiency virus/AIDS-coinfected patients under tuberculosis treatment.
Ngouleun W; Biapa Nya PC; Pieme AC; Telefo PB
Int J Mycobacteriol; 2016 Dec; 5(4):482-488. PubMed ID: 27931691
[TBL] [Abstract][Full Text] [Related]
2. Abnormal Levels of Liver Enzymes and Hepatotoxicity in HIV-Positive, TB, and HIV/TB-Coinfected Patients on Treatment in Fako Division, Southwest Region of Cameroon.
Enoh JE; Cho FN; Manfo FP; Ako SE; Akum EA
Biomed Res Int; 2020; 2020():9631731. PubMed ID: 32462039
[TBL] [Abstract][Full Text] [Related]
3. Anti-TB drug concentrations and drug-associated toxicities among TB/HIV-coinfected patients.
Sekaggya-Wiltshire C; von Braun A; Scherrer AU; Manabe YC; Buzibye A; Muller D; Ledergerber B; Gutteck U; Corti N; Kambugu A; Byakika-Kibwika P; Lamorde M; Castelnuovo B; Fehr J; Kamya MR
J Antimicrob Chemother; 2017 Apr; 72(4):1172-1177. PubMed ID: 28108678
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and risk factors of anti-tuberculosis drug-induced hepatitis in Malaysia.
Marzuki OA; Fauzi AR; Ayoub S; Kamarul Imran M
Singapore Med J; 2008 Sep; 49(9):688-93. PubMed ID: 18830542
[TBL] [Abstract][Full Text] [Related]
5. [Drug-induced hepatotoxicity caused by anti-tuberculosis drugs in tuberculosis patients complicated with chronic hepatitis].
Kaneko Y; Nagayama N; Kawabe Y; Shimada M; Suzuki J; Kunogi M; Matsui Y; Kawashima M; Suzuki J; Ariga H; Oshima N; Masuda K; Matsui H; Nagai H; Tamura A; Akagawa S; Toyoda E; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2008 Jan; 83(1):13-9. PubMed ID: 18283910
[TBL] [Abstract][Full Text] [Related]
6. Incidence of antituberculosis-drug-induced hepatotoxicity and associated risk factors among tuberculosis patients in Dawro Zone, South Ethiopia: A cohort study.
Wondwossen Abera ; Waqtola Cheneke ; Gemeda Abebe
Int J Mycobacteriol; 2016 Mar; 5(1):14-20. PubMed ID: 26927985
[TBL] [Abstract][Full Text] [Related]
7. Antituberculosis drugs and hepatotoxicity among hospitalized patients in Jos, Nigeria.
Isa SE; Ebonyi AO; Shehu NY; Idoko P; Anejo-Okopi JA; Simji G; Odesanya RU; Abah IO; Jimoh HO
Int J Mycobacteriol; 2016 Mar; 5(1):21-6. PubMed ID: 26927986
[TBL] [Abstract][Full Text] [Related]
8. Hepatotoxicity due to rifampicin, isoniazid and pyrazinamide in patients with tuberculosis: is anti-HCV a risk factor?
Nader LA; de Mattos AA; Picon PD; Bassanesi SL; De Mattos AZ; Pineiro Rodriguez M
Ann Hepatol; 2010; 9(1):70-4. PubMed ID: 20308724
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of tuberculosis patients in the integrated tuberculosis control model in Chongqing, China: a retrospective study.
Zhang L; Xing W; Zhou J; Zhang R; Cheng Y; Li J; Wang G; Liu S; Li Y
BMC Infect Dis; 2020 Aug; 20(1):576. PubMed ID: 32758169
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced hepatotoxicity of anti-tuberculosis drugs and their serum levels.
Jeong I; Park JS; Cho YJ; Yoon HI; Song J; Lee CT; Lee JH
J Korean Med Sci; 2015 Feb; 30(2):167-72. PubMed ID: 25653488
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of risk factors for antituberculosis treatment induced hepatotoxicity.
Singla R; Sharma SK; Mohan A; Makharia G; Sreenivas V; Jha B; Kumar S; Sarda P; Singh S
Indian J Med Res; 2010 Jul; 132():81-6. PubMed ID: 20693595
[TBL] [Abstract][Full Text] [Related]
12. Hepatotoxicity during TB treatment in people with HIV/AIDS related to NAT2 polymorphisms in Pernambuco, Northeast Brazil.
Araujo-Mariz C; Militão de Albuquerque MFP; Lopes EP; Ximenes RAA; Lacerda HR; Miranda-Filho DB; Lustosa-Martins BB; Pastor AFP; Acioli-Santos B
Ann Hepatol; 2020; 19(2):153-160. PubMed ID: 31734174
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, drug-induced hepatotoxicity, and mortality among patients multi-infected with HIV, tuberculosis, and hepatitis virus.
Mo P; Zhu Q; Teter C; Yang R; Deng L; Yan Y; Chen J; Zeng J; Gui XE
Int J Infect Dis; 2014 Nov; 28():95-100. PubMed ID: 25218771
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of TB/HIV co-infected patients presenting with antituberculosis drug-induced liver injury.
Naidoo S; Evans D; Jong E; Mellet K; Berhanu R
S Afr Med J; 2015 Apr; 105(5):393-6. PubMed ID: 26242667
[TBL] [Abstract][Full Text] [Related]
15. Viral hepatitis prevalence in patients with active and latent tuberculosis.
Nooredinvand HA; Connell DW; Asgheddi M; Abdullah M; O'Donoghue M; Campbell L; Wickremasinghe MI; Lalvani A; Kon OM; Khan SA
World J Gastroenterol; 2015 Aug; 21(29):8920-6. PubMed ID: 26269682
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function.
Padmapriyadarsini C; Chandrabose J; Victor L; Hanna LE; Arunkumar N; Swaminathan S
J Postgrad Med; 2006; 52(2):92-6. PubMed ID: 16679670
[TBL] [Abstract][Full Text] [Related]
17. An official ATS statement: hepatotoxicity of antituberculosis therapy.
Saukkonen JJ; Cohn DL; Jasmer RM; Schenker S; Jereb JA; Nolan CM; Peloquin CA; Gordin FM; Nunes D; Strader DB; Bernardo J; Venkataramanan R; Sterling TR;
Am J Respir Crit Care Med; 2006 Oct; 174(8):935-52. PubMed ID: 17021358
[TBL] [Abstract][Full Text] [Related]
18. Hepatotoxicity in patients co-infected with tuberculosis and HIV-1 while receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy and rifampicin-containing anti-tuberculosis regimen.
Mankhatitham W; Lueangniyomkul A; Manosuthi W
Southeast Asian J Trop Med Public Health; 2011 May; 42(3):651-8. PubMed ID: 21706943
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of efavirenz in patients on antituberculosis treatment in high human immunodeficiency virus and tuberculosis burden countries: A systematic review.
Atwine D; Bonnet M; Taburet AM
Br J Clin Pharmacol; 2018 Aug; 84(8):1641-1658. PubMed ID: 29624706
[TBL] [Abstract][Full Text] [Related]
20. Antituberculosis drug-induced hepatotoxicity: a comparison between patients with and without human immunodeficiency virus seropositivity.
Coca NS; Oliveira MS; Voieta I; Antunes CM; Lambertucci JR
Rev Soc Bras Med Trop; 2010; 43(6):624-8. PubMed ID: 21181011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
